CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L603. A total of 28 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,669 | +57.9% | 30,745 | +165.3% | 0.00% | – |
| Q2 2023 | $6,756 | -18.8% | 11,588 | -20.1% | 0.00% | – |
| Q1 2023 | $8,325 | -47.6% | 14,509 | -39.1% | 0.00% | – |
| Q4 2022 | $15,884 | -62.2% | 23,814 | -38.1% | 0.00% | – |
| Q2 2022 | $42,000 | -40.8% | 38,500 | +66.5% | 0.00% | – |
| Q1 2022 | $71,000 | -39.8% | 23,130 | -24.1% | 0.00% | – |
| Q4 2021 | $118,000 | -83.5% | 30,487 | -77.6% | 0.00% | – |
| Q3 2021 | $717,000 | -51.7% | 136,165 | -45.7% | 0.00% | – |
| Q2 2021 | $1,485,000 | -28.9% | 250,797 | -14.7% | 0.00% | -100.0% |
| Q1 2021 | $2,090,000 | – | 293,867 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 250,000 | $365,000 | 0.05% |
| McIlrath & Eck, LLC | 26,342 | $38,000 | 0.01% |
| Schonfeld Strategic Advisors LLC | 615,200 | $898,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 367,477 | $535,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 12,800 | $19,000 | 0.00% |
| Point72 Asset Management, L.P. | 230,000 | $336,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 61,816 | $90,000 | 0.00% |
| STATE STREET CORP | 10,510 | $15,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 195,445 | $285,000 | 0.00% |
| MORGAN STANLEY | 1,200 | $2,000 | 0.00% |